Search Results - Ballantyne, C.

New therapeutic principles in dyslipidaemia: Focus on LDL and Lp(a) lowering drugs by Norata, Giuseppe, Ballantyne, C., Catapano, A.

Get full text

Troponin T, NT-proBNP, and Incidence of Stroke: The Atherosclerosis Risk in Communities (ARIC) Study by Folsom, A., Nambi, V., Bell, E., Oluleye, O., Gottesman, R., Lutsey, P., Huxley, Rachel, Ballantyne, C.

Get full text

Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: The atherosclerosis risk in communities study by Folsom, A., Nambi, V., Bell, E., Oluleye, O., Gottesman, R., Lutsey, P., Huxley, Rachel, Ballantyne, C.

Get full text

High-Sensitivity Cardiac Troponin T and the Risk of Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study by Filion, K., Agarwal, S., Ballantyne, C., Hoogeveen, R., Huxley, Rachel, Loehr, L., Nambi, V., Soliman, E., Alonso, A.

Get full text

Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: The atherosclerosis risk in communities study by Lopez, F., Agarwal, S., MacLehose, R., Soliman, E., Sharrett, A., Huxley, Rachel, Konety, S., Ballantyne, C., Alonso, A.

Get full text

High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study by Filion, K., Agarwal, S., Ballantyne, C., Eberg, M., Hoogeveen, R., Huxley, Rachel, Loehr, L., Nambi, V., Soliman, E., Alonso, A.

Get full text